| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| H Okazawa, M Murata, M Watanabe, M Kamei, I Kanazaw. Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum. FEBS letters. vol 313. issue 2. 1992-12-22. PMID:1358675. |
these data suggest that dopaminergic stimulation directly promotes the expression of bdnf in the striatum in vivo. |
1992-12-22 |
2023-08-11 |
mouse |
| A Björklun. Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Current opinion in neurobiology. vol 2. issue 5. 1992-12-22. PMID:1422126. |
the results provide evidence that behaviorally functional grafts restore dopaminergic neurotransmission and normalize dopamine receptor function in the denervated striatum, and that these effects are likely to depend on both synaptic and extrasynaptic mechanisms. |
1992-12-22 |
2023-08-11 |
rat |
| C Milio, M G Hadfiel. Ethanol alters monoamines in specific mouse brain regions. Brain research bulletin. vol 29. issue 5. 1992-12-15. PMID:1422857. |
for the dopaminergic system, da was decreased in the olfactory tubercle, dopac was increased in the prefrontal cortex and septum, and dopac/da was increased in the prefrontal cortex, septum, striatum, and hypothalamus. |
1992-12-15 |
2023-08-11 |
mouse |
| G W Huntley, J H Morrison, A Prikhozhan, S C Sealfo. Localization of multiple dopamine receptor subtype mRNAs in human and monkey motor cortex and striatum. Brain research. Molecular brain research. vol 15. issue 3-4. 1992-12-14. PMID:1331674. |
thus, not only does primate neocortex possess a broader representation of the dopamine receptor subtype mrnas examined in comparison with striatum, but the unexpected presence and widespread distribution of d2 and d5 receptor mrnas in cortex suggests that, along with d1 receptors, d2 and d5 receptors play a crucial role in the dopaminergic modulation of cognition and motor behavior, and in dopamine dysfunction associated with neuropsychiatric disorders. |
1992-12-14 |
2023-08-11 |
human |
| F C Liu, S B Dunnett, A M Graybie. Influence of mesostriatal afferents on the development and transmitter regulation of intrastriatal grafts derived from embryonic striatal primordia. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 12. issue 11. 1992-12-11. PMID:1279138. |
striatal grafts derived from embryonic day 15 striatal primordia were implanted into the ibotenate-damaged host striatum of rats previously treated with 6-hydroxydopamine (6-ohda) to destroy th-containing dopaminergic nigrostriatal afferents. |
1992-12-11 |
2023-08-11 |
rat |
| F C Liu, S B Dunnett, A M Graybie. Influence of mesostriatal afferents on the development and transmitter regulation of intrastriatal grafts derived from embryonic striatal primordia. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 12. issue 11. 1992-12-11. PMID:1279138. |
despite the fact that dopaminergic denervation of the host striatum did not disrupt either the aggregation of grafted cells into p regions or the acquisition of striatal neurochemical phenotypes by cells in the p regions, there were clear differences between the staining patterns of these grafts and grafts placed into dopamine-innervated striatum. |
1992-12-11 |
2023-08-11 |
rat |
| R E Burke, A Macaya, D DeVivo, N Kenyon, E M Jane. Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons. Neuroscience. vol 50. issue 3. 1992-12-10. PMID:1359461. |
it has been shown that morphologic and biochemical presynaptic markers of dopaminergic terminals are preserved in a unilateral experimental model of neonatal hypoxic-ischemic injury to the striatum. |
1992-12-10 |
2023-08-11 |
human |
| R E Burke, A Macaya, D DeVivo, N Kenyon, E M Jane. Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons. Neuroscience. vol 50. issue 3. 1992-12-10. PMID:1359461. |
as the substantia nigra is spared direct injury in this model, we anticipated that the number of tyrosine hydroxylase-positive dopaminergic neurons projecting to the striatum would also be normal. |
1992-12-10 |
2023-08-11 |
human |
| S N Schiffmann, J J Vanderhaeghe. Lesion of the nigrostriatal pathway induces cholecystokinin messenger RNA expression in the rat striatum. An in situ hybridization histochemistry study. Neuroscience. vol 50. issue 3. 1992-12-10. PMID:1436504. |
these results suggest that the dopaminergic nigrostriatal pathway directly, or indirectly, regulates the expression of cholecystokinin messenger rna in the striatum. |
1992-12-10 |
2023-08-11 |
rat |
| M Santiago, B H Westerin. The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual-probe microdialysis study in awake rats. European journal of pharmacology. vol 219. issue 2. 1992-12-07. PMID:1330605. |
a microdialysis probe implanted into the substantia nigra was used to infuse gamma-aminobutyric acid-ergic (gabaergic) compounds onto cell bodies/dendrites of dopaminergic neurons, while a second microdialysis probe was used to record the extracellular concentrations of dopamine and 3,4-dihydroxy-phenylacetic acid (dopac) in the ipsilateral striatum. |
1992-12-07 |
2023-08-11 |
rat |
| R P Iacono, Z S Tang, J C Mazziotta, S Grafton, M Hoeh. Bilateral fetal grafts for Parkinson's disease: 22 months' results. Stereotactic and functional neurosurgery. vol 58. issue 1-4. 1992-12-07. PMID:1439354. |
pet utilizing [18f]-dopa, at 14 months in the first case, suggested graft-induced restoration of dopaminergic transmission in the striatum. |
1992-12-07 |
2023-08-11 |
Not clear |
| M Otsuka, Y Ichiya, F Shima, Y Kuwabara, M Sasaki, T Fukumura, M Kato, K Masuda, I Got. Increased striatal 18F-dopa uptake and normal glucose metabolism in idiopathic dystonia syndrome. Journal of the neurological sciences. vol 111. issue 2. 1992-12-04. PMID:1431986. |
these findings suggest that pathogenetic mechanism of idiopathic dystonia involves increased presynaptic activity of the dopaminergic system in the striatum. |
1992-12-04 |
2023-08-11 |
Not clear |
| M A Chapman, R E See, G Bissett. Neurotensin increases extracellular striatal dopamine levels in vivo. Neuropeptides. vol 22. issue 3. 1992-12-01. PMID:1436404. |
these results suggest that nt differentially affects in vivo da release in the striatum and nucleus accumbens, and further strengthens the assertion that nt is an important modulator of dopaminergic function. |
1992-12-01 |
2023-08-11 |
rat |
| M J Eaton, Y Tian, K J Lookingland, K E Moor. Comparison of the effects of remoxipride and raclopride on nigrostriatal and mesolimbic dopaminergic neuronal activity and on the secretion of prolactin and alpha-melanocyte-stimulating hormone. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 7. issue 3. 1992-11-19. PMID:1326981. |
although raclopride was consistently more potent than remoxipride, both drugs produced dose- and time-related increases in concentrations of 3,4-dihydroxyphenylacetic acid in the striatum and nucleus accumbens, which contain terminals of nigrostriatal and mesolimbic dopaminergic neurons, respectively. |
1992-11-19 |
2023-08-11 |
rat |
| H Nissbrandt, N Waters, S Hjort. The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn-Schmiedeberg's archives of pharmacology. vol 346. issue 1. 1992-11-19. PMID:1328893. |
the influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. |
1992-11-19 |
2023-08-11 |
rat |
| H Nissbrandt, N Waters, S Hjort. The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn-Schmiedeberg's archives of pharmacology. vol 346. issue 1. 1992-11-19. PMID:1328893. |
the effects of serotoninergic drugs on dopaminergic neurotransmission in the substantia nigra, the striatum and the limbic forebrain of rat have been investigated. |
1992-11-19 |
2023-08-11 |
rat |
| E Panula-Lehto, M Mäkinen, L Ahte. Effects of taurine, homotaurine and GABA on hypothalamic and striatal dopamine metabolism. Naunyn-Schmiedeberg's archives of pharmacology. vol 346. issue 1. 1992-11-19. PMID:1407006. |
to elucidate the effects of taurine on hypothalamic and striatal dopaminergic neurotransmission we compared its effects to those of gamma-aminobutyric acid (gaba) and homotaurine (a gabaa-receptor agonist) on hypothalamic and striatal concentrations of dopamine (da) and its metabolites, 3,4-dihydroxyphenylacetic acid (dopac), homovanillic acid (hva) and, in the case of striatum, 3-methoxytyramine (3-mt) in rats. |
1992-11-19 |
2023-08-11 |
rat |
| A M Allen, D P MacGregor, S Y Chai, G A Donnan, S Kaczmarczyk, K Richardson, R Kalnins, J Ireton, F A Mendelsoh. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Annals of neurology. vol 32. issue 3. 1992-11-13. PMID:1416803. |
we propose, from these results, that angiotensin receptors in the striatum are located presynaptically on dopaminergic terminals projecting from the substantia nigra. |
1992-11-13 |
2023-08-11 |
human |
| A Elverfors, H Nissbrand. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum. Neuropharmacology. vol 31. issue 7. 1992-11-06. PMID:1328918. |
effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum. |
1992-11-06 |
2023-08-11 |
rat |
| A Elverfors, H Nissbrand. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum. Neuropharmacology. vol 31. issue 7. 1992-11-06. PMID:1328918. |
the effects of d-amphetamine (d-amp) on dopaminergic neurotransmission in the cell body/dendritic region of the nigrostriatal pathway, the substantia nigra, have been investigated and compared to the effects obtained in the terminal region of the pathway, the striatum. |
1992-11-06 |
2023-08-11 |
rat |